Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 36317-36318 [2014-14974]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 123 / Thursday, June 26, 2014 / Notices
Following closure of the public
comment period, an EPA contractor will
organize and conduct an independent
expert external letter peer review of the
draft criterion document. Public
comments will be made available to the
peer reviewers for consideration during
their review. Following peer review,
EPA will consider the peer reviewer and
public comments, and revise the
document as necessary. EPA will then
publish a Federal Register notice
announcing the availability of the draft
proposed selenium criterion and
soliciting scientific views from the
public. EPA will then revise the
document as necessary and issue a final
updated selenium criterion document.
Dated: June 18, 2014.
Elizabeth Southerland,
Director, Office of Science and Technology.
[FR Doc. 2014–14995 Filed 6–25–14; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL MARITIME COMMISSION
tkelley on DSK3SPTVN1PROD with NOTICES
Ocean Transportation Intermediary
License Applicants
The Commission gives notice that the
following applicants have filed an
application for an Ocean Transportation
Intermediary (OTI) license as a NonVessel-Operating Common Carrier
(NVO) and/or Ocean Freight Forwarder
(OFF) pursuant to section 19 of the
Shipping Act of 1984 (46 U.S.C. 40101).
Notice is also given of the filing of
applications to amend an existing OTI
license or the Qualifying Individual (QI)
for a licensee.
Interested persons may contact the
Office of Ocean Transportation
Intermediaries, Federal Maritime
Commission, Washington, DC 20573, by
telephone at (202) 523–5843 or by email
at OTI@fmc.gov.
A Active Freezone Cargo Inc. (NVO),
2315 NW 107th Avenue, Box 55, Suite
IM33, Miami, FL 33172, Officers:
Pauk Mak, Operation Manager (QI),
Chenyu Cai, President, Application
Type: QI Change.
Braid Projects (USA), LLC (OFF), 5642
Shirley Lane, Houston, TX 77032,
Officers: Kostas G. Chalos, President
(QI), Shane Watson, Vice President,
Application Type: New OFF License.
Core One Logistics LLC (NVO & OFF),
2665 S. Park Lane, Pembroke Park, FL
33009, Officer: Etan Raz, Manager/
Member (QI), Application Type: New
NVO & OFF License.
Domex Superfresh Growers, LLC dba
DSG Logistics (OFF), 151 Low Road,
Yakima, Washington 98908, Officers:
Kevin Kershaw, Director of DSG
VerDate Mar<15>2010
16:51 Jun 25, 2014
Jkt 232001
Logistics (QI), Robert Kershaw,
President, Application Type: New
OFF License.
FA Logistics International Corp. (NVO),
8070 NW 71st Street, Miami, FL
33166, Officers: Franklin Almeida,
President (QI), Rosi Lucendo, Vice
President, Application Type: New
NVO License.
Iramat Shipping and Logistics LLC
(OFF), 947 Main Street, Rear Building
A, West Warwick, RI 02893, Officer:
Hakeem B. Alabi, Managing Member
(QI), Application Type: New OFF
License.
M & S Logistics, L.L.C. (NVO), 6302
Broadway Street, Suite 120, Pearland,
TX 77581, Officers: Willem J.
Roldaan, Manager (QI), David R. Kew,
Manager, Application Type: Add
Trade Name M&S Logistics.
Oddessa Imports, Corp. (NVO & OFF),
8209 Northwest 68th Street, Miami,
FL 33166, Officer: Gustavo A. Lozano,
President (QI), Application Type:
New NVO & OFF License.
Paza Motors, Inc. (NVO & OFF), 5433
Buffalo Avenue, Suite B, Jacksonville,
FL 32208, Officers: Mona A. Hussein,
President (QI), Mohammad A.
Hussein, Vice President, Application
Type: New NVO & OFF License.
Superior International Group Inc.
(NVO), 3833 Schaefer Avenue, Suite
F, Chino, CA 91710, Officers: Steven
Wong, President (QI), Lisa Wong,
Secretary, Application Type: Transfer
to VMS International Inc.
USTC Global, Inc. (NVO), 20695 S.
Western Avenue, Suite 132, Torrance,
CA 90501, Officers: Michael Suh, CEO
(QI), Youngeui Kim, CFO, Application
Type: QI Change.
By the Commission.
Dated: June 20, 2014.
Karen V. Gregory,
Secretary.
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns the Pilot Program of Mailed
Fecal Immunochemical Tests to Increase
Colorectal Cancer Screening Rates,
Special Interest Projects (SIP) 14–012;
the Understanding the Barriers to
Colorectal Cancer Screening among
Frm 00032
Fmt 4703
South Central Asian Immigrants in the
United States, SIP–14–013; and the
Development and Evaluation of Active
Surveillance Decision aid for Men with
Low-grade, Local-stage Prostate Cancer,
SIP–14–014, Panel D, initial review.
Summary: This document corrects a
notice that was published in the Federal
Register on June 6, 2014 (79 FR 32737–
32738). The time and date should read
as follows:
Time and Date: 9:30 a.m.–3:30 p.m.,
June 19, 2014 (Closed).
For Further Information Contact:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., F.A.C.E., Deputy Associate
Director for Science, National Center for
Injury Prevention and Control, CDC,
4770 Buford Highway NE., Mailstop
F63, Atlanta, Georgia 30341, Telephone:
(770) 488–4655, GXC8@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–14975 Filed 6–25–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
[FR Doc. 2014–14957 Filed 6–25–14; 8:45 am]
PO 00000
36317
Sfmt 4703
The meeting announced below
concerns Health Promotion and Disease
Prevention Research Centers: Special
Interest Project Competitive
Supplements DP–14–011, initial review.
Summary: This document corrects a
notice that was published in the Federal
Register on June 12, 2014 (79 FR 33755).
This meeting is cancelled in its entirety.
Contact Person for More Information:
M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F–80, Atlanta,
Georgia 30341, Telephone: (770) 488–
3585, EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
E:\FR\FM\26JNN1.SGM
26JNN1
36318
Federal Register / Vol. 79, No. 123 / Thursday, June 26, 2014 / Notices
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–14974 Filed 6–25–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
tkelley on DSK3SPTVN1PROD with NOTICES
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
16:51 Jun 25, 2014
Jkt 232001
Food and Drug Administration,
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
information collection associated with
the Medical Device ISO 13485:2003
Voluntary Audit Report Submission
Pilot Program.
DATES: Submit either electronic or
written comments on the collection of
information by August 25, 2014.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
SUMMARY:
The meeting announced below
concerns the Agricultural, Forestry and
Fishing Safety and Health Research
(U01) PAR–14–175, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:00 p.m.–4:30 p.m.,
July 15, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Agricultural, Forestry and Fishing
Safety and Health Research (U01) PAR–
14–175.’’
Contact Person for More Information:
Joan F. Karr, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1600 Clifton Road,
Mailstop E–74, Atlanta, Georgia 30333,
Telephone: (404) 498–2506.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Mar<15>2010
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Guidance: Medical
Device ISO 13485:2003 Voluntary Audit
Report Submission Pilot Program
HHS.
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
BILLING CODE 4163–18–P
[Docket No. FDA–2014–N–0797]
AGENCY:
Centers for Disease Control and
Prevention
[FR Doc. 2014–14976 Filed 6–25–14; 8:45 am]
Food and Drug Administration
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Guidance: Medical Device ISO
13485:2003 Voluntary Audit Report
Submission Pilot Program—(OMB
Control Number 0910–0700)—Extension
Under section 228 of the Food and
Drug Administration Amendments Act
of 2007 (Pub. L. 110–85), as amended by
section 704(g)(7) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C.
374(g)(7)), the owner or operator of an
establishment may submit an audit
report that assesses conformance with
appropriate quality system standards set
by the International Organization for
Standardization (ISO) and identified by
the Secretary in public notice.
The ‘‘Guidance for Industry, Third
Parties and FDA Staff: Medical Device
ISO 13485:2003 Voluntary Audit Report
Submission Program’’ describes how
FDA’s Center for Devices and
Radiological Health and Center for
Biologics Evaluation and Research are
implementing this provision of the law
and providing public notice as required.
The proposed collections of information
are necessary to satisfy the previously
mentioned statutory requirements for
implementing this voluntary submission
program. The collected information is
used for setting risk-based inspectional
priorities.
The ‘‘Guidance for Industry, Third
Parties, and FDA Staff: Medical Device
ISO 13485:2003 Voluntary Audit Report
Submission Program’’ describes how
FDA’s Center for Devices and
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 79, Number 123 (Thursday, June 26, 2014)]
[Notices]
[Pages 36317-36318]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14974]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Health Promotion and Disease
Prevention Research Centers: Special Interest Project Competitive
Supplements DP-14-011, initial review.
Summary: This document corrects a notice that was published in the
Federal Register on June 12, 2014 (79 FR 33755). This meeting is
cancelled in its entirety.
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80,
Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the
[[Page 36318]]
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-14974 Filed 6-25-14; 8:45 am]
BILLING CODE 4163-18-P
